GLPwatch

Insulin Secretion Depends on Intra-islet Glucagon Signaling.

Cell Rep · 2018

Last updated 2026-05-28

In a study on mice, researchers found that glucagon helps control insulin secretion through two pathways: the glucagon receptor (Gcgr) and the GLP-1 receptor (GLP-1R). Blocking both receptors together significantly reduced insulin secretion, while blocking either one alone did not change insulin levels. The study also detected active GLP-1 in pancreatic fluid only when the glucagon receptor was removed, suggesting glucagon may indirectly boost insulin by activating GLP-1.

AI summary of the abstract below.

JournalCell Rep, 2018
Citations275
Relative citation ratio11.78
NIH percentile98
Molecules
Conditions studied Type 2 Diabetes

Abstract

The intra-islet theory states that glucagon secretion is suppressed when insulin secretion is stimulated, but glucagon's role in intra-islet paracrine regulation is controversial. This study investigated intra-islet functions of glucagon in mice. We examined glucagon-induced insulin secretion using isolated perfused pancreata from wild-type, GLP-1 receptor (GLP-1R) knockout, diphtheria toxin-induced proglucagon knockdown, β cell-specific glucagon receptor (Gcgr) knockout, and global Gcgr knockout (Gcgr) mice. We found that glucagon stimulates insulin secretion through both Gcgr and GLP-1R. Moreover, loss of either Gcgr or GLP-1R does not change insulin responses, whereas combined blockage of both receptors significantly reduces insulin secretion. Active GLP-1 is identified in pancreatic perfusate from Gcgr but not wild-type mice, suggesting that β cell GLP-1R activation results predominantly from glucagon action. Our results suggest that combined activity of glucagon and GLP-1 receptors is essential for β cell secretory responses, emphasizing a role for paracrine intra-islet glucagon actions to maintain appropriate insulin secretion.

Verbatim abstract via PubMed 30380405 ↗